(S,R,S)-AHPC-PEG2-NH2 hydrochloride

 CAS No.: 2097973-72-1  Cat No.: BP-100042  Purity: 95% 4.5  

(S,R,S)-AHPC-PEG2-NH2 hydrochloride is a high-purity E3 ligase ligand-linker conjugate designed specifically for PROTAC (Proteolysis Targeting Chimera) drug development. This molecule features the AHPC (aryl hydroxyproline carboxamide) core, a well-validated ligand for recruiting the Von Hippel-Lindau (VHL) E3 ligase, connected to an amino-terminated polyethylene glycol (PEG2) linker. The hydrochloride salt offers enhanced solubility and stability, making it suitable for chemical synthesis and PROTAC assembly. Ideal for researchers in medicinal chemistry and drug discovery, (S,R,S)-AHPC-PEG2-NH2 hydrochloride accelerates the design and synthesis of VHL-based PROTACs targeting a wide array of proteins, including kinases, transcription factors, and epigenetic regulators. Explore the possibilities of targeted protein degradation with this versatile, research-grade reagent.

(S,R,S)-AHPC-PEG2-NH2 hydrochloride

Structure of 2097973-72-1

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
E3 Ligase Ligand-Linker Conjugate
Molecular Formula
C28H42ClN5O6S
Molecular Weight
612.18
Appearance
White to Yellow Solid

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
100 mg $299 In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Purity
95%
Appearance
White to Yellow Solid
ShelfLife
2 years
Storage
Store at 2-8 °C
IUPACName
(2S,4R)-1-[(2S)-2-[[2-[2-(2-aminoethoxy)ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;hydrochloride
Synonyms
E3 ligase Ligand-Linker Conjugates 6; VHL Ligand-Linker Conjugates 3 hydrochloride
InChI Key
SYAOHFUUVWFWJH-ZBXLSASTSA-N
InChI
InChI=1S/C28H41N5O6S.ClH/c1-18-24(40-17-31-18)20-7-5-19(6-8-20)14-30-26(36)22-13-21(34)15-33(22)27(37)25(28(2,3)4)32-23(35)16-39-12-11-38-10-9-29;/h5-8,17,21-22,25,34H,9-16,29H2,1-4H3,(H,30,36)(H,32,35);1H/t21-,22+,25-;/m1./s1
SMILES
CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCN)O.Cl

Background Introduction

(S,R,S)-AHPC-PEG2-NH2 hydrochloride is a specialized E3 ligase ligand-linker conjugate widely utilized in the design and synthesis of PROTACs (Proteolysis Targeting Chimeras). Based on the AHPC (hydroxyproline-based) scaffold, this molecule incorporates a hydrophilic PEG2 spacer and a terminal amine functionality, making it ideal for conjugation to target-binding ligands. The AHPC derivative confers high affinity for the von Hippel-Lindau (VHL) E3 ubiquitin ligase, a critical component in targeted protein degradation strategies.

Mechanism

The mode of action for (S,R,S)-AHPC-PEG2-NH2 hydrochloride is centered on its application as the E3 ligase ligand portion of PROTAC molecules. When chemically linked via its terminal NH2 group to a ligand that binds a protein of interest (POI), the resulting heterobifunctional PROTAC brings the E3 ligase (VHL) into close proximity with the POI. This spatial proximity enables the transfer of ubiquitin molecules from the ligase complex to the target protein, effectively marking it for recognition and subsequent degradation by the cellular proteasome. The PEG2 linker enhances solubility and provides the necessary flexibility and distance to facilitate efficient ternary complex formation and ubiquitination.

Applications

(S,R,S)-AHPC-PEG2-NH2 hydrochloride is mainly used in the synthesis of PROTAC-based drug candidates and research tools. By serving as a core building block for linking E3 ligase ligands to protein-targeting moieties, it enables the rapid development of novel small-molecule degraders for various disease-related proteins. Common applications include studying degradation mechanisms for undruggable targets, generating potent and selective chemical probes, and creating next-generation therapeutic molecules for cancer, neurodegeneration, and other diseases leveraging targeted protein degradation. Researchers in medicinal chemistry, chemical biology, and drug discovery frequently utilize this compound for constructing custom PROTAC libraries and optimizing protein degrader activity.

• Highly selective VHL E3 ligase ligand enables targeted protein degradation applications.
• PEG2 linker improves solubility and cell permeability, streamlining PROTAC synthesizing workflows.

The (S,R,S)-AHPC-PEG2-NH2 hydrochloride serves as an essential E3 Ligase Ligand-Linker Conjugate in the development of PROTACs, facilitating targeted protein degradation by effectively bridging the E3 ligase and target protein. The following provides a detailed description of this molecule's linker, ligand, and selection of target protein ligands.

Linker: This molecule features a PEG2 linker, which is characterized by its moderate length and flexibility, allowing for optimal spatial arrangement between the ligand and the target protein. The PEG2 linker is non-cleavable, ensuring stability throughout the degradation process.

Ligand: The ligand in this molecule is an AHPC derivative, known for its high affinity and specificity towards the E3 ligase. Structurally, it is designed to maintain robust binding while facilitating the recruitment of the ligase to the target protein.

Reactive Site: The reactive site of the (S,R,S)-AHPC-PEG2-NH2 hydrochloride is the terminal amine group. This site is suitable for coupling with target protein ligands through amide bond formation or other nucleophilic substitution reactions, ensuring efficient conjugation.

Recommended Target Protein Ligand: Compatible warheads for this molecule include electrophilic groups such as acrylamides or chloroacetamides, which can form covalent bonds with cysteine residues on target proteins. These warheads are advantageous due to their ability to ensure irreversible binding, providing a robust approach for the degradation of challenging protein targets in experimental studies.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket